MiR-137-derived polygenic risk: effects on cognitive performance in patients with schizophrenia and controls.
about
Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies.Cognitive Characterization of Schizophrenia Risk Variants Involved in Synaptic Transmission: Evidence of CACNA1C's Role in Working Memory.Genetic association analysis of microRNA137 and its target complex 1 with schizophrenia in Han Chinese.A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia.Association of With Symptom Severity and Cognitive Functioning in Belarusian Schizophrenia Patients
P2860
MiR-137-derived polygenic risk: effects on cognitive performance in patients with schizophrenia and controls.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
MiR-137-derived polygenic risk ...... th schizophrenia and controls.
@en
MiR-137-derived polygenic risk ...... th schizophrenia and controls.
@nl
type
label
MiR-137-derived polygenic risk ...... th schizophrenia and controls.
@en
MiR-137-derived polygenic risk ...... th schizophrenia and controls.
@nl
prefLabel
MiR-137-derived polygenic risk ...... th schizophrenia and controls.
@en
MiR-137-derived polygenic risk ...... th schizophrenia and controls.
@nl
P2093
P2860
P50
P356
P1476
MiR-137-derived polygenic risk ...... th schizophrenia and controls.
@en
P2093
A Richards
D W Morris
K Mantripragada
O Mothersill
Wellcome Trust Case Control Consortium
P2860
P2888
P356
10.1038/TP.2016.286
P50
P577
2017-01-24T00:00:00Z
P6179
1074187531